Warfarin Best for Thrombotic Antiphospholipid Syndrome?
Patients with thrombotic antiphospholipid syndrome appear better treated with a vitamin K antagonist such as warfarin, rather than a direct oral anticoagulant, a new meta-analysis suggests.
Stay updated with breaking news from Meta Analysis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Patients with thrombotic antiphospholipid syndrome appear better treated with a vitamin K antagonist such as warfarin, rather than a direct oral anticoagulant, a new meta-analysis suggests.
"There is an urgent need to explore novel treatment approaches that can be safely, feasibly, and widely implemented in the daily routine of depressed children and adolescents."
"Based on low‐ to moderate-certainty evidence,” the review concludes, “skin care interventions such as emollients during the first year of life … are probably not effective for preventing eczema.”
The analysis suggests that PIK3CA mutation is associated with worse pathologic complete response and other outcomes. The study was published as a preprint and has not yet been peer reviewed.
Taking more steps per day is associated with progressively lower risk of heart disease, but the benefits are seen at fewer than 10,000 steps per day, new research suggests.